Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2009 3
2010 1
2011 3
2012 17
2013 33
2014 34
2015 40
2016 27
2017 37
2018 27
2019 21
2020 30
2021 23
2022 18
2023 31
2024 15
2025 6
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

322 results

Results by year

Filters applied: . Clear all
Page 1
Enfortumab vedotin plus pembrolizumab in treatment-naïve metastatic urothelial carcinoma patients: An Austrian real-world analysis.
Niedersuess-Beke D, Mayrhofer K, Krauter J, Franke J, Vais D, Pallauf M, Kiesl D, Luger F, Pfuner J, Terbuch A, Bauernhofer T, Spielgelberg J, Banner A, Aufderklamm S, Wiesinger C, Schnabel S, Gampenrieder SP, Mühlmann J, Vallet S, Weibrecht S, Stoiber F, Andalibi H, Fajkovic H, Taghizadeh H, Miechowiecki J, Taedcke R, Heintel D, Shariat SF, Pichler M, Hilbe W, Pichler R. Niedersuess-Beke D, et al. Among authors: pichler m. Int J Cancer. 2026 Mar 15;158(6):1654-1665. doi: 10.1002/ijc.70203. Epub 2025 Oct 22. Int J Cancer. 2026. PMID: 41123038 Free PMC article.
FGFR1/3 Signaling as an Achilles' Heel of Phenotypic Diversity in Urothelial Carcinoma.
Pichler R, van Creij NCH, Mertens LS, Del Giudice F, Koll F, Soria F, Subiela JD, Plage H, Tymoszuk P, Mayr R, Klinglmair G, Seeber A, Pichler M, Günther M, Ormanns S, Compérat E, Li R, Moschini M, Pradére B; European Association of Urology-Young Academic Urologists Urothelial Carcinoma Working Group. Pichler R, et al. Among authors: pichler m. Eur Urol Oncol. 2025 Jul 26:S2588-9311(25)00197-X. doi: 10.1016/j.euo.2025.07.005. Online ahead of print. Eur Urol Oncol. 2025. PMID: 40716983 Free article.
Pembrolizumab-axitinib versus nivolumab-cabozantinib as first-line therapy in patients with metastatic renal cell carcinoma: a retrospective real-world comparison (ARON-1).
Santoni M, Roviello G, Grande E, De Giorgi U, Fiala O, Seront E, Molina-Cerrillo J, Pichler R, Myint ZW, Kucharz J, Kanesvaran R, Büttner T, Pichler M, Basso U, Kopecky J, Bourlon MT, Cerbone L, Buchler T, Pinto A, de Liaño AG, Gianni C, Zgura A, Rescigno P, Ansari J, Caffo O, Küronya Z, Vitale MG, Bhuva D, Catalano M, Vau N, Kopp RM, Buti S, Bamias A, Porta C, Sunela K, Massari F. Santoni M, et al. Among authors: pichler m. Cancer Immunol Immunother. 2025 May 27;74(7):225. doi: 10.1007/s00262-025-04043-x. Cancer Immunol Immunother. 2025. PMID: 40423789 Free PMC article.
Arterial thromboembolic events in testicular cancer patients: short- and long-term incidence, risk factors, and impact on mortality.
Moik F, Terbuch A, Sprakel A, Pichler G, Barth DA, Pichler R, Rainer P, Silbernagel G, Mannweiler S, Jost PJ, Ahyai SA, Bauernhofer T, Hutterer GC, Pichler M. Moik F, et al. Among authors: pichler m. J Thromb Haemost. 2025 Sep;23(9):2796-2806. doi: 10.1016/j.jtha.2025.01.022. Epub 2025 Feb 14. J Thromb Haemost. 2025. PMID: 39956429 Free article.
Real-world Evidence for Enfortumab Vedotin in Patients with Metastatic Urothelial Cancer: An Austrian Multicentre Study.
Niedersuess-Beke D, Mayrhofer K, Krauter J, Schnabel S, Gampenrieder SP, Miechowiecki J, Kiesl D, Luger F, Pfuner J, Wiesinger C, Vallet S, Andalibi H, Vais D, Banner A, Stoiber F, Spielgelberg J, Barth D, Bauernhofer T, Aufderklamm S, Weibrecht S, Mühlmann J, Mayer M, Hilbe W, Boulmé F, Klinglmair G, Heintel D, Shariat SF, Pichler M, Pichler R. Niedersuess-Beke D, et al. Among authors: pichler m. Clin Genitourin Cancer. 2025 Feb;23(1):102278. doi: 10.1016/j.clgc.2024.102278. Epub 2024 Nov 22. Clin Genitourin Cancer. 2025. PMID: 39672785 Free article.
Tumor Suppressor miR-27a-5p and Its Significance for Breast Cancer.
Parrella P, Barbano R, Jonas K, Fontana A, Barile S, Rendina M, Lo Mele A, Prencipe G, Ciuffreda L, Morritti MG, Valori VM, Graziano P, Maiello E, Copetti M, Pichler M, Pasculli B. Parrella P, et al. Among authors: pichler m. Biomedicines. 2024 Nov 17;12(11):2625. doi: 10.3390/biomedicines12112625. Biomedicines. 2024. PMID: 39595190 Free PMC article.
Primary tumor ablation in metastatic renal cell carcinoma.
Scheipner L, Incesu RB, Morra S, Baudo A, Jannello LMI, Siech C, de Angelis M, Assad A, Tian Z, Saad F, Shariat SF, Briganti A, Chun FKH, Tilki D, Longo N, Carmignani L, De Cobelli O, Pichler M, Ahyai S, Karakiewicz PI. Scheipner L, et al. Among authors: pichler m. Urol Oncol. 2025 May;43(5):332.e11-332.e18. doi: 10.1016/j.urolonc.2024.10.019. Epub 2024 Nov 12. Urol Oncol. 2025. PMID: 39537442 Free article.
Clinical features and response to immune combinations in patients with renal cell carcinoma and sarcomatoid de-differentiation (ARON-1 study).
Ciccarese C, Büttner T, Cerbone L, Zampiva I, Monteiro FSM, Basso U, Pichler M, Vitale MG, Fiala O, Roviello G, Kopp RM, Carrozza F, Pichler R, Grillone F, Calabuig EP, Zeppellini A, Küronya Z, Galli L, Facchini G, Sunela K, Mosca A, Molina-Cerrillo J, Spinelli GP, Ansari J, Scala A, Mollica V, Grande E, Buti S, Kanesvaran R, Zakopoulou R, Bamias A, Rizzo M, Massari F, Iacovelli R, Santoni M. Ciccarese C, et al. Among authors: pichler m. Int J Cancer. 2024 Dec 1;155(11):2036-2046. doi: 10.1002/ijc.35141. Epub 2024 Sep 7. Int J Cancer. 2024. PMID: 39243397
322 results